<html><body><h2>Case: 1811949</h2><h3> CDS Time: 1973-05-22</h3>
<patient name=1811949>
73.0 year old Black_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">73</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">114</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Glucose</td><td width="200">87</td><td width="200">1971-3-29</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">6</td><td width="200">1972-10-28</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">46</td><td width="200">1972-12-30</td></tr>
<tr><td width="200">Chloride</td><td width="200">93.0</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">95</td><td width="200">1972-12-30</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">66</td><td width="200">1973-5-15</td></tr>
<tr><td width="200">BNP</td><td width="200">9,087</td><td width="200">1973-3-13</td></tr>
<tr><td width="200">B 12</td><td width="200">953.0</td><td width="200">1971-3-29</td></tr>
<tr><td width="200">Weight</td><td width="200">111</td><td width="200">1973-5-15</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">4</td><td width="200">1973-2-12</td></tr>
<tr><td width="200">HbA1C</td><td width="200">5</td><td width="200">1972-4-12</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">103</td><td width="200">1972-12-30</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">161</td><td width="200">1972-12-30</td></tr>
<tr><td width="200">SGOT</td><td width="200">39</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">127</td><td width="200">1973-5-15</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Height</td><td width="200">63</td><td width="200">1973-1-29</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">161</td><td width="200">1972-12-30</td></tr>
<tr><td width="200">BUN</td><td width="200">35</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">HCT</td><td width="200">42</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Sodium</td><td width="200">130</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Creatinine</td><td width="200">7.1</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">5</td><td width="200">1972-4-12</td></tr>
<tr><td width="200">Pulse</td><td width="200">78</td><td width="200">1973-5-15</td></tr>
<tr><td width="200">PLT</td><td width="200">192</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">WBC</td><td width="200">8</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">SGPT</td><td width="200">38</td><td width="200">1973-5-4</td></tr>
<tr><td width="200">Race</td><td width="200">Black_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Hepatitis_B_Surface_Antigen</td><td width="200">Negative</td><td width="200">1970-9-28</td></tr>
<tr><td width="200">Tobacco_Use</td><td width="200"></td><td width="200">1972-12-13</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1973-4-2</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1973-4-2</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1973-2-19</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1972-8-18</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1973-4-2</td></tr>
<tr><td width="200">smoking</td><td width="200"></td><td width="200">1972-12-13</td></tr>
<tr><td width="200">tobacco use</td><td width="200"></td><td width="200">1972-12-13</td></tr>
<tr><td width="200">Obstructive_Pulmonary_Disease</td><td width="200"></td><td width="200">1973-1-29</td></tr>
<tr><td width="200">Osteoporosis</td><td width="200"></td><td width="200">1973-5-10</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1973-4-2</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1973-2-19</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1973-4-2</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) labetalol(400.0) spironolactone(25.0) losartan(50.0) atorvastatin(40.0) nitrate(30.0) hydralazine(20.0) carvedilol(12.5) furosemide(80.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(130.0/1973-5-4)]()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Significant hyponatremia[Sodium(130.0/1973-5-4)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(7.1/1973-5-4)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of cononary artery disease]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(66/null) && Treatment_Systolic_BP(127/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Sodium=<125 ever</td>
<td width="200"></td>
<td width="200"> hyponatremia in the past[Sodium(130.0/1973-5-4)]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(66/null) && Treatment_Systolic_BP(127/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(73.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of lipid disorder ICD9]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(73.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Active prescription for ARB and aldosterone antagonist</td>
<td width="200"></td>
<td width="200"> Active prescription for ARB and aldosterone antagonist[Presence of ARB && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Female and most recent creatinine  >2</td>
<td width="200"></td>
<td width="200"> Female and most recent creatinine  >2[Sex(Female) && Creatinine(7.1/1973-5-4)]()</td></tr>
<tr><td width="200">Osteoporosis</td>
<td width="200">1973-05-10</td>
<td width="200"> Osteoporosis()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1973-04-02</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1973-02-19</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1973-04-02</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1973-04-02</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1972-12-13</td>
<td width="200"> Tobacco_Use()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1973-04-02</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Respiratory_Diseases</td>
<td width="200">1973-01-29</td>
<td width="200"> Obstructive_Pulmonary_Disease()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1970-09-28</td>
<td width="200"> Hepatitis_B_Surface_Antigen()
<tr> <td width="200"></td>
<td width="200">1973-04-02</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1973-02-19</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200">1972-12-13</td>
<td width="200"> tobacco use()
<tr> <td width="200"></td>
<td width="200">1972-08-18</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200">1972-12-13</td>
<td width="200"> smoking()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 130 mg/dL(2+ Risk Factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(46.0/1972-12-30))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(66/null) && Treatment_Systolic_BP(127/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>aldosterone antagonist<ul><li>Already being used<li>Contraindications:  Female and most recent creatinine  >2(Female and most recent creatinine  >2[Sex(Female) && Creatinine(7.1/1973-5-4)]) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Relative contraindications:  Active prescription for ARB and aldosterone antagonist(Active prescription for ARB and aldosterone antagonist[Presence of ARB && presence of aldosterone antagonist]) <li>preference: neutral</ul><li>ARB<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>